J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)
India · Delayed Price · Currency is INR 2,416.10
+7.20 (0.30%)
Jul 16, 2026, 3:29 PM IST
NSE:JBCHEPHARM Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 41,478 | 41,478 | 39,180 | 34,842 | 31,493 | 24,242 |
Revenue Growth | 5.87% | 5.87% | 12.45% | 10.63% | 29.91% | 18.69% |
Gross Profit Gross Profit Growth | 28,109 | 28,109 | 25,635 | 22,700 | 19,530 | 15,588 |
Operating Income Operating Income Growth | 9,228 | 9,228 | 8,600 | 7,544 | 5,918 | 4,739 |
Net Income Net Income Growth | 7,095 | 7,095 | 6,596 | 5,526 | 4,098 | 3,854 |
Earnings Per Share EPS Growth | 44.45 | 44.45 | 41.56 | 34.85 | 26.17 | 24.91 |
EPS Growth | 6.95% | 6.95% | 19.25% | 33.17% | 5.06% | -14.04% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
India India Growth | 24,735 | 24,735 | 22,688 | 18,979 | 16,396 | 11,882 |
outside India outside India Growth | 16,742 | 16,742 | 16,492 | 15,863 | 15,096 | 12,360 |
Total Total Growth | 41,478 | 41,478 | 39,180 | 34,842 | 31,493 | 24,241 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 12,213 | 12,213 | 4,501 | 4,596 | 2,692 | 566.5 |
Total Debt Total Debt Growth | 35.89 | 35.89 | 278.9 | 3,777 | 5,724 | 545.59 |
Net Cash (Debt) Net Cash Growth | 12,178 | 12,178 | 4,222 | 819.79 | -3,032 | 20.92 |
Net Cash Growth | 188.43% | 188.43% | 415.01% | - | - | -99.68% |
Net Cash Per Share Net Cash Per Share Growth | 76.29 | 76.29 | 26.61 | 5.17 | -19.36 | 0.14 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 7,039 | 7,039 | 9,024 | 8,006 | 6,286 | 1,701 |
Capital Expenditures CapEx Growth | -831.89 | -831.89 | -975.88 | -1,269 | -724.61 | -628.7 |
Free Cash Flow Free Cash Flow Growth | 6,207 | 6,207 | 8,049 | 6,737 | 5,562 | 1,073 |
Free Cash Flow Growth | -22.88% | -22.88% | 19.46% | 21.14% | 418.51% | -59.83% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 67.77% | 67.77% | 65.43% | 65.15% | 62.01% | 64.30% |
Operating Margin | 22.25% | 22.25% | 21.95% | 21.65% | 18.79% | 19.55% |
Pretax Margin | 22.96% | 22.96% | 22.65% | 21.57% | 17.63% | 20.83% |
Profit Margin | 17.11% | 17.11% | 16.84% | 15.86% | 13.01% | 15.90% |
FCF Margin | 14.96% | 14.96% | 20.54% | 19.34% | 17.66% | 4.42% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 22.000 | 22.000 | 15.500 | 12.250 | 8.875 | 8.250 |
Dividend Per Share Growth | 41.94% | 41.94% | 26.53% | 38.03% | 7.58% | 0% |
Dividend Yield | 0.91% | 1.07% | 0.97% | 0.76% | 0.92% | 1.09% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 54.59 | 46.69 | 38.29 | 46.32 | 37.21 | 31.59 |
P/FCF Ratio | 62.40 | 53.37 | 31.38 | 37.99 | 27.42 | 113.49 |
PS Ratio | 9.34 | 7.99 | 6.45 | 7.35 | 4.84 | 5.02 |